Kate Hermans Email and Phone Number
Chair I Board Member I Strategic Advisor I CEO I Business Builder I Pharmaceuticals I Biotech I HealthTech at
@
Clue by Biowink
Kate Hermans's Location
Wayne, Pennsylvania, United States, United States
Kate Hermans's Contact Details
Kate Hermans work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Kate Hermans personal email
- Valid
Kate Hermans phone numbers
About Kate Hermans
Public & Private Board Chair / Director. Advisor to biotech start-ups. Investor. C-Suite Executive with a passion for building businesses and solutions for stakeholders on the front lines of healthcare. Two successful exits with a unique ability to unlock potential and deliver exceptional financial outcomes across venture-backed and public companies.
Kate Hermans's Current Company Details
Clue By Biowink
View
Chair I Board Member I Strategic Advisor I CEO I Business Builder I Pharmaceuticals I Biotech I HealthTech
Kate Hermans Work Experience Details
-
ChairClue By Biowink May 2022 - PresentBerlin, DeClue is a trusted reproductive health resource, protector of data privacy, and thought leader in Femtech. Developed by the Berlin-based technology company BioWink GmbH, Clue combines science and technology to actively changing the way people learn, access, and talk about menstrual and reproductive health around the world.
-
Board MemberMid-Atlantic Diamond Ventures (Madv) Apr 2022 - PresentPhiladelphia, Pennsylvania, UsMADV is a leading organization that assists emerging, technology-based companies in their effort to build sustainable businesses by better positioning them for funding while increasing value at an early and crucial stage. -
Non-Executive DirectorAmbrx Jun 2022 - Mar 2024San Diego, Ca, UsOn March 7th, 2024, Johnson & Johnson successfully completed the acquisition of Ambrx for approximately $2B .Ambrx (NYSE: AMAM) - clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics in multiple cancer indications. -
Interim Chief Executive Officer / PresidentAmbrx Aug 2022 - Nov 2022San Diego, Ca, UsLed a rapid and thorough pipeline assessment which resulted in a strategic turnaround, reprioritization of new lead asset, doubling the cash runway, and streamlined corporate governance and operations. (https://www.fiercebiotech.com/biotech/esmo-ambrxs-reset-arrives-last-line-prostate-cancer-offering-not-one-serious-adverse-event)
-
Founder And CeoHermans International Llc Jan 2012 - Aug 2022Advisory firm for startup and early-stage enterprises that strategically positions companies to maximize their value creation.
-
Chief Business Officer - Pharma83Bar, The Patient Activation Company Dec 2018 - Jul 2021Austin, Texas, UsInvestor and Chief Business Officer (Pharma) of a private digital health technology company focused on the patient UX for both commercial and clinical trial applications. -
Vice President, MarketingRadius Health, Inc. Mar 2017 - Apr 2018Boston, Ma, UsGlobal biopharmaceutical company (~$200M) focused on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. Successfully launched TYMLOS™ into a highly competitive marketplace with award-winning creative campaigns. Re-engineered launch strategy while launching and exceeded Y1 revenue goals in specialty pharmacy/hub delivery model (reached 39% NBRx, 29% TRx, $99.2M by 2018 EOY). -
Head, Specialty Portfolio Commercialization StrategyBristol-Myers Squibb Jul 2016 - Mar 2017Lawrence Township, Nj, UsLed New Product Planning team. Set commercialization strategy for the BMS specialty portfolio. Responsible for New Product / Pipeline development, Business Development, M&A. Resulted in out licensing (GDD), partnering (CV), and acceleration (immunology, fibrosis) of select assets in the portfolio. -
General Manager, Orencia & Hcv (Worldwide / Global)Bristol-Myers Squibb May 2014 - Jun 2016Lawrence Township, Nj, UsLed the successful turnaround of Orencia® resulting in +15-20% growth YOY and +64% sales increase in 4 years. Led continued acceleration of HCV franchise, recognized by analysts for its positive impact on patients and BMS growth in the face of intense competition. Drove growth of both franchises by nearly $1B combined during tenure to $4B. Founded company’s first equity & diversity-focused executive leadership development program (LEAD).
-
Vice President, Global Brand Development & CommercializationBristol-Myers Squibb Sep 2012 - May 2014Lawrence Township, Nj, UsHead of Immunology pipeline commercialization. Shaped company portfolio vision through creation of robust immunology franchise strategy, laying groundwork for future BMS strategic M&A.
-
Senior Director (Avp Equivalent), Global Commercial Operations | Business Excellence ConsultingPfizer Jul 2011 - Dec 2011New York, New York, UsCo-led global organizational redesign, creating Pfizer’s Global Commercial Operations (GCO) center of excellence in 4 months (synergized 17 groups, 1100+ colleagues and $685M in spend across commercial operations, training, multi-channel marketing, business analytics) -
General Manager, Vaccines Bu - ChinaPfizer Oct 2009 - Jul 2011New York, New York, UsBuilt $51M business unit and industry-leading commercial team (330 sales, marketing & operations) resulting in 150% growth in net sales and IBT for 2010. Received industry recognition for most successful multinational product launch (Prevenar®) since 1999 (IMS), through DTC innovation and public health commitments.
-
Assoc. Vice President, Pharma Bu - ChinaPfizer Jun 2009 - Oct 2009New York, New York, UsLed $90M business successfully through Pfizer acquisition (800 commercial, operations, and distribution professionals). Recognized by China Pharma Industry Association (RDPAC) as the fastest growing company in China with +67% 1H09 vs. 1H08 (45% FY).
-
Marketing Director - Product Launch | New Products | Commercial Strategy & Operations - ChinaPfizer Aug 2008 - May 2009New York, New York, UsHead of Marketing, China responsible for 5 in-line products, 1 launch product, and 5 therapeutic areas (vaccines, CNS, women’s health, antibiotics and transplant). Achieved $59M net sales (+59% vs. 2007), successfully launched Prevenar®, exceeding vaccination rate target by 28% (Q2 2009), and built organizational capability in marketing, new product planning, and market research.
-
Executive Director, Global Strategic Marketing - Rapamune® (Transformed Commercial Strategy)Pfizer Sep 2007 - Aug 2008New York, New York, Us
-
Senior Director, Marketing - Protonix® (Product Management | Commercial Strategy)Pfizer Jan 2005 - Sep 2007New York, New York, Us
-
Executive Director, Pharma Bu Global Business Operations ("Chief Of Staff")Pfizer Jun 2003 - Dec 2004New York, New York, Us
-
Executive Director, Global Strategic Sourcing (Built Best-In-Class Coe)Pfizer Oct 1998 - Jun 2003New York, New York, Us
-
Commodity ManagerIntel Corporation 1994 - 1998Santa Clara, California, Us -
Consultant21St Century Africa 1993 - 1994
-
Trade SpecialistMa Office Of International Trade & Investment 1990 - 1992
Kate Hermans Skills
Cross Functional Team Leadership
Product Launch
Strategy
Pharmaceutical Industry
Global Marketing
Business Strategy
Strategic Planning
Management
Leadership
Market Research
Marketing Strategy
Business Development
Marketing
Change Management
Contract Negotiation
Market Planning
Oncology
Pharmaceutical Sales
P&l Management
Market Analysis
Competitive Analysis
Team Building
Commercialization
Driving Results
Marketing Management
Brand Development
Brand Management
Six Sigma
Biopharmaceuticals
Pricing
Sales Operations
Project Management
Segmentation
Training
Cultural Awareness
Market Access
Sales Effectiveness
Vaccines
Healthcare
Lifesciences
International Business
Competitive Intelligence
Strategic Thinking
Change Leadership
Leadership Development
Budgets
Business Ethics
Hospital Sales
International Marketing
Product Marketing
Kate Hermans Education Details
-
Thunderbird School Of Global ManagementFinance -
Wheaton College MassachusettsInternational Relations (Political Science And Economics)
-
InseadCedep International General Management Program
-
Sciences PoPolitical Science & Economics
-
Conestoga High School
Frequently Asked Questions about Kate Hermans
What company does Kate Hermans work for?
Kate Hermans works for Clue By Biowink
What is Kate Hermans's role at the current company?
Kate Hermans's current role is Chair I Board Member I Strategic Advisor I CEO I Business Builder I Pharmaceuticals I Biotech I HealthTech.
What is Kate Hermans's email address?
Kate Hermans's email address is he****@****bms.com
What is Kate Hermans's direct phone number?
Kate Hermans's direct phone number is +161042*****
What schools did Kate Hermans attend?
Kate Hermans attended Thunderbird School Of Global Management, Wheaton College Massachusetts, Insead, Sciences Po, Conestoga High School.
What skills is Kate Hermans known for?
Kate Hermans has skills like Cross Functional Team Leadership, Product Launch, Strategy, Pharmaceutical Industry, Global Marketing, Business Strategy, Strategic Planning, Management, Leadership, Market Research, Marketing Strategy, Business Development.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial